[1]RAJA K,JACOB M,ASTHANA S.Portal vein thrombosis in cirrhosis[J].J Clin Exp Hepatol,2014,4(4):320-331.
|
[2]HARDING DJ,PERERA MT,CHEN F,et al.Portal vein thrombosis in cirrhosis:controversies and latest developments[J].World J Gastroenterol,2015,21(22):6769-6784.
|
[3]FRANCOZ C,VALLA D,DURAND F.Portal vein thrombosis,cirrhosis,and liver transplantation[J].J Hepatol,2012,57(1):203-212.
|
[4]CHEN H,TRILOK G,WANG F,et al.A single hospital study on portal vein thrombosis in cirrhotic patients-clinical characteristics&risk factors[J].Indian J Med Res,2014,139(2):260-266.
|
[5]WEBSTER GJ,BURROUGHS AK,RIORDAN SM.Review article:portal vein thrombosis-new insights into aetiology and management[J].Aliment Pharmacol Ther,2005,21(1):1-9.
|
[6]DELEVE LD,VALLA DC,GARCIA TG.Vascular disorders of the liver[J].Hepatology,2009,49(5):1729-1764.
|
[7]GAO PJ,GAO J,LI Z,et al.Liver transplantation in adults with portal vein thrombosis:data from the China Liver Transplant Registry[J].Clin Res Hepatol Gastroenterol,2016,40(3):327-332.
|
[8]ENGLESBE MJ,KUBUS J,MUHAMMAD W,et al.Portal vein thrombosis and survival in patients with cirrhosis[J].Liver Transpl,2010,16(1):83-90.
|
[9]KINJO N,KAWANAKA H,AKAHOSHI T,et al.Portal vein thrombosis in liver cirrhosis[J].World J Hepatol,2014,6(2):64-71.
|
[10]NERY F,CHEVRET S,CONDAT B,et al.Causes and consequences of portal vein thrombosis in 1243 patients with cirrhosis:results of a longitudinal study[J].Hepatology,2015,61(2):660-667.
|
[11]MARUYAMA H,OKUGAWA H,TAKAHASH M,et al.De novo portal vein thrombosis in virus-related cirrhosis:predictive factors and long-term outcomes[J].Am J Gastroenterol,2013,108(4):568-574.
|
[12]ZOCCO MA,DI STASIO E,DE CRISTOFARO R,et al.Thrombotic risk factors in patients with liver cirrhosis:correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol,2009,51(4):682-689.
|
[13]QI X,LI H,LIU X,et al.Novel insights into the development of portal vein thrombosis in cirrhosis patients[J].Expert Rev Gastroenterol Hepatol,2015,9(11):1421-1432.
|
[14]KAWANAKA H,AKAHOSHI T,KINJO N,et al.Impact of antithrombinⅢconcentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism[J].Ann Surg,2010,251(1):76-83.
|
[15]QI X,CHEN H,HAN G.Effect of antithrombin,protein C and protein S on portal vein thrombosis in liver cirrhosis:a meta-analysis[J].Am J Med Sci,2013,346(1):38-44.
|
[16]CHEN H,QI X,HE C,et al.Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis[J].Thromb Res,2013,131(2):173-177.
|
[17]WU S,WU Z,ZHANG X,et al.The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization[J].Turk J Gastroenterol,2015,26(5):423-428.
|
[18]AMITRANO L,BRANCACCIO V,GUARDASCIONE MA,et al.Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis[J].Hepatology,2000,31(2):345-348.
|
[19]ZHANG WW,QI XS,GUO XZ.Significance of factorⅡG20210A mutation in Budd-Chiari syndrome and portal vein thrombosis[J].J Clin Hepatol,2015,31(2):310-314.(in Chinese)张文文,祁兴顺,郭晓钟.凝血因子ⅡG20210A突变在布加综合征和门静脉血栓形成中的意义[J].临床肝胆病杂志,2015,31(2):310-314.
|
[20]QI X,REN W,DE SV,et al.Associations of coagulation factor VLeiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis:a systematic review and meta-analysis[J].Clin Gastroenterol Hepatol,2014,12(11):1801-1812.
|
[21]MANGIA A,VILLANI MR,CAPPUCCI G,et al.Causes of portal venous thrombosis in cirrhotic patients:the role of genetic and biologic factors[J].Eur J Gastroenterol Hepatol,2005,17(7):745-751.
|
[22]MA J,YAN Z,LUO J,et al.Rational classification of portal vein thrombosis and its clinical significance[J].PLoS One,2014,9(11):e112501.
|
[23]SENZOLO M,TIBBALS J,CHOLOMGITAS E,et al.Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation[J].Aliment Pharmacol Ther,2006,23(6):767-775.
|
[24]PONZIANI FR.Portal vein thrombosis:insight into physiopathology,diagnosis,and treatment[J].World J Gastroenterol,2010,16(2):143.
|
[25]TREBICHA J,STRASSBURG CP.Etiology and complications of portal vein thrombosis[J].Viszeralmedizin,2014,30(6):375-380.
|
[26]TSOCHATZIS EA,BOSCH J,BURROGHS AK.Liver cirrhosis[J].The Lancet,2014,383(9930):1749-1761.
|
[27]QI X,HAN G,WANG J,et al.Degree of portal vein thrombosis[J].Hepatology,2010,51(3):1089-1090.
|
[28]RAJESH S,MUKUND A,ARORA A.Imaging diagnosis of splanchnic venous thrombosis[J].Gastroenterol Res Pract,2015,2015:101029.
|
[29]BERZIGOTTI A,GARCA-CRIADO A,DARNELL A,et al.Imaging in clinical decision-making for portal vein thrombosis[J].Nat Rev Gastroenterol Hepatol,2014,11(5):308-316.
|
[30]AGENO W,RIVA N,SCHULMAN S,et al.Long-term clinical outcomes of splanchnic vein thrombosis:results of an international registry[J].JAMA Intern Med,2015,175(9):1474-1480.
|
[31]CUI SB,SHU RH,YAN SP,et al.Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B[J].Eur J Gastroenterol Hepatol,2015,27(8):914-919.
|
[32]CHEN H,LIU L,QI X,et al.Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis[J].Eur J Gastroenterol Hepatol,2016,28(1):82-89.
|
[33]HUARD G,BILODEAU M.Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis:a systematic review[J].Int J Hepatol,2012,2012:672986.
|
[34]CONGLY SE,LEE SS.Portal vein thrombosis:should anticoagulation be used?[J].Curr Gastroenterol Rep,2013,15(2):306.
|
[35]RODRIGUEZ-CASTRO KI,SIMIONI P,BURRA P,et al.Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis[J].Liver International,2012,32(10):1465-1476.
|
[36]QI X,HAN G,FAN D.Management of portal vein thrombosis in liver cirrhosis[J].Nat Rev Gastroenterol Hepatol,2014,11(7):435-446.
|
[37]WANG Z,JIANG MS,ZHANG HL,et al.Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis?A randomized controlled trial[J].Radiology,2016,279(3):943-951.
|
[38]UFLACHER R.Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis[J].Tech Vasc Interv Radiol,2003,6(1):59-69.
|
[39]BERRY K,TAYLOR J,LIOU IW,et al.Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis[J].Clin Gastroenterol Hepatol,2015,13(3):585-593.
|
[40]QI X,DAI J,YANG M,et al.Association between portal vein thrombosis and survival in non-liver-transplant patients with liver cirrhosis:a systematic review of the literature[J].Gastroenterol Res Pract,2015,2015:480842.
|
[41]ENGLESBE MJ,SCHAUBEL DE,CAI S,et al.Portal vein thrombosis and liver transplant survival benefit[J].Liver Transpl,2010,16(8):999-1005.
|
[42]JOHN BV,KONJETI R,AGGRAWAL A,et al.Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis[J].Ann Hepatol,2013,12(6):952-958.
|
[43]RAMOS AP,REIGADA CPH,ATADE EC,et al.Portal vein thrombosis and liver transplantation:long term[J].Transplant Proc,2010,42(2):498-501.
|
[44]GHABRI M,AGARWAL S,LACERDA M,et al.Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation:analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients[J].Transplantation,2016,100(1):126-133.
|